Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666912 · ClinicalTrials.gov registry record · Phase 4
Postpartum Etonogestrel Implant for Adolescents
A Phase 4 study of Contraception and Postpartum, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT01666912: Completed Phase 4 study of Contraception and Postpartum, sponsored by University of North Carolina, Chapel Hill.
NCT01666912 is a Phase 4 study of Contraception and Postpartum that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 96 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01666912, a Phase 4 study of Contraception and Postpartum, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study comparing two groups of 48 adolescent women each. The intervention group will receive a contraceptive implant postpartum, prior to discharge from the hospital. The control group will receive a contraceptive implant at the usual 6 week postpartum clinic visit. During prenatal care, participants will be consented and screened for enrollment. After delivery, these women will be assessed and consented for enrollment into the study. Women who consent for enrollment will be randomized. Women will be followed up at 3 months, 6 months, 9 months, and 1 year after contraceptive implant insertion. At each follow up, women will be assessed for continuation of and satisfaction with this method of contraception.
Primary Outcome
The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.
Conditions Studied
Interventions
- DRUG Contraceptive implant
Study Locations (1)
North Carolina
- University of North Carolina Hospitals - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
What the finished NCT01666912 record still lists
NCT01666912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Contraceptive implant is the first listed.
NCT01666912 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01666912 about?
NCT01666912 is a clinical study titled "Postpartum Etonogestrel Implant for Adolescents". This is a prospective study comparing two groups of 48 adolescent women each. The intervention group will receive a contraceptive implant postpartum, prior to discharge from the hospital. The control group will receive a contraceptive implant at the usual 6 week postpartum clinic visit. During prena...
What is the current status of trial NCT01666912?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2012-08. Estimated completion is 2015-04.
What conditions does trial NCT01666912 study?
This clinical trial studies the following conditions: Contraception, Postpartum, Adolescence.
What interventions are being tested in trial NCT01666912?
The interventions under investigation include: Contraceptive implant (DRUG).
Who is sponsoring clinical trial NCT01666912?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666912 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01666912's enrollment target sits among peer trials
96 44th of 72 higher than 29 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
RECRUITING · Phase 4
-
Etonogestrel Implant as Emergency Contraception
RECRUITING · Phase 4
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
Impact of Combined Hormonal Contraceptives on UPA
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia